Acquisition of Bioline Group (Tables)

9 Months Ended

Jun. 30, 2011

Acquisition of Bioline Group (Tables) [Abstract]

Consolidated results of the company

	Three			Nine
	Months			Months
	Ended			Ended
	June 30, 2011			June 30, 2011
Net Sales	$	3,905		$	10,966
Operating Income (Loss)	$	83		$	(91	)
Net (Loss) Earnings	$	(31	)	$	28

Amounts of identifiable assets acquired and liabilities assumed

	July 20,
	2010		Measurement			July 20,
	(as initially		Period			2010
	reported)		Adjustments			(as adjusted)
Fair value of assets acquired -
Cash and equivalents	$	3,445				$	3,445
Accounts receivable		1,897					1,897
Inventories		2,807					2,807
Other current assets		371	$	(21	)		350
Property, plant and equipment, net		816					816
Goodwill		13,166		(174	)		12,992
Other intangible assets (estimated useful life):
Customer relationships (10 years)		3,898					3,898
Manufacturing processes (6 years)		1,467					1,467
License agreements (approx. 8 year wtd. avg.)		718					718
Non-compete agreements (1 year)		122					122
Trade names (10 years)		995					995
		29,702		(195	)		29,507
Fair value of liabilities assumed -
Accounts payable and accrued expenses		2,817		364			3,181
Deferred income tax liabilities		3,036		(559	)		2,477
Total consideration paid	$	23,849	$	—		$	23,849

Consolidated pro forma results of the combined entities

	Three Months				Nine Months
	Ended June 30,				Ended June 30,
	2011		2010		2011		2010
Net Sales	$	40,052	$	37,361	$	118,374	$	117,208
Net Earnings	$	6,857	$	7,201	$	20,565	$	20,757
Diluted Earnings Per Common Share	$	0.17	$	0.17	$	0.50	$	0.50